Remove 2018 Remove Pharmaceutical manufacturing Remove Sales
article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. Conducting internal pre-sale checks and looking at your level of compliance and licenses is a vital exercise. It is also an ideal opportunity to simplify as well as harmonise.

Pharma 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Warnings for Japanese pharmaceutical market may lead to more lenient price controls

Pharmaceutical Technology

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

article thumbnail

The real motivation for COVID vaccine development

World of DTC Marketing

The study found that of the various high R&D manufacturing industries, the telephone industry retains 61% of total spending, the auto industry retains 68% and the computer industry retains 67%. One exception is Moderna, a relatively new pharmaceutical company which had no approved products for sale as recently as 2019.

Pharma 180